首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer research

缩写:CANCER RES

ISSN:0008-5472

e-ISSN:1538-7445

IF/分区:22.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引12921条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Huayuan Liu,Yiqiao Deng,Yi Yang et al. Huayuan Liu et al.
Perineural invasion (PNI) is a common pathological feature associated with poor prognosis of colorectal cancer (CRC). A better understanding of the mechanisms underlying PNI formation could help identify potential strategies to inhibit tumo...
Yan-Na Lei,Diyuan Qin,Yan He et al. Yan-Na Lei et al.
Limited intratumoral persistence and insufficient proliferative capacity severely restrict the efficacy of chimeric antigen receptor (CAR)-T cell therapies in solid tumors. Here, we demonstrated that DLL3-targeting CAR-T cells co-expressing...
Philippa A Burns,Negar Tabatabaei,Laura M Selfors et al. Philippa A Burns et al.
Serine is a critical nutrient for cancer cell proliferation due to its numerous downstream biosynthetic functions. Given the ongoing clinical efforts to utilize dietary serine starvation as a potential therapy for serine auxotrophic tumors,...
Tiantian Ma,Jibo Wu,Siting Li et al. Tiantian Ma et al.
Microsatellite instability-high (MSI-H) colorectal cancer cells depend on the Werner syndrome helicase (WRN) to resolve cruciform DNA structures that arise from expanded TA-dinucleotide repeats. Loss of WRN induces replication stress and do...
Xiaoxue Pan,Yuhang Yin,Haopeng Hong et al. Xiaoxue Pan et al.
While chimeric antigen receptor (CAR) T cell therapy has demonstrated significant efficacy in treating hematological malignancies, its application in solid tumors remains challenging. A major limitation of CAR-T cell efficacy in solid tumor...
Sarah Kolitz,Anna Travesa,Amy Axel et al. Sarah Kolitz et al.
Inappropriate activation of the mitogen-activated protein kinase (MAPK) pathway, often stemming from activating mutations in RAS or RAF, represents one of the most common oncogenic events in human cancer. However, currently approved RAS/RAF...
Linyan Chen,Tang Feng,Jianfeng Zhou et al. Linyan Chen et al.
Neoadjuvant immunochemotherapy (nICT) has emerged as a promising neoadjuvant strategy for esophageal squamous cell carcinoma (ESCC). Identification of the factors affecting the responsiveness to nICT could help further improve treatment eff...
Kaixin Cheng,Hao Nie,Wei Zhou et al. Kaixin Cheng et al.
Poly(ADP-ribose) polymerase inhibitors (PARPi) are a first-line treatment for epithelial ovarian cancer (EOC) patients, but the development of resistance limits long-term therapeutic efficacy. Tumor acidosis is a hallmark of the tumor micro...
Linda Mårtensson,Petra Holmkvist,Kirstie L Cleary et al. Linda Mårtensson et al.
Although checkpoint inhibitors have revolutionized cancer treatment, responses are largely restricted to targeting CTLA-4 and PD-(L)1. TNFR2 has been identified as a promising target, but further therapeutic development requires a better un...
Neta Solomon,Ye&#x;ela Scharff,Yuval Rubinstein et al. Neta Solomon et al.
High-grade serous (tubo-ovarian) carcinoma (HGSC) is the most lethal gynecologic malignancy and the most common form of ovarian cancer. Most patients (75%) are diagnosed at advanced disease stages, with widespread peritoneal dissemination l...